, Singapore
549 views
Photo by Nadine Shabana via Unsplash.

MAS revokes insurance broker license of Acesynergy Brokers

ABPL failed to comply with regulatory requirements.

The Monetary Authority of Singapore (MAS) has cancelled the registration of Acesynergy Brokers Pte. Ltd (ABPL) as an insurance broker, effective 24 July.

ABPL is no longer permitted to operate an insurance broking business in Singapore.

ABPL has reportedly returned all remaining policyholders’ moneys and connected them with their respective insurers, MAS said in a press release.

The cancellation comes as ABPL failed to comply with applicable regulatory requirements, registration conditions, and written directions from MAS. 

These included ABPL’s failure to submit annual regulatory returns on time, arrange for the audit of annual regulatory returns, and appoint the required minimum number of broking staff, the financial authority said.

MAS particularly found “significant weaknesses” in ABPL’s management oversight, and its accounting and compliance processes.

“ABPL further failed to comply with MAS’ written directions to remediate the inspection findings and appoint an independent external person to review its remediation measures. This was despite MAS’ repeated engagements with its chief executive officer and director, Mr Tan Chuan Lam,” MAS said in a statement.

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.